Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|November 12, 2019
A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancerKathleen N Moore, Austin Miller, Katherine M Bell-McGuinn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 2, 2020
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group studyDana Chase, Helen Q Huang, Bradley J Monk, et al.
Molecular Cancer Research : MCR|August 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent MannerLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Gynecologic Oncology|February 21, 2021
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology studyJessica Gillen, Austin Miller, Katherine M Bell-McGuinn, et al.
Gynecologic Oncology|April 11, 2017
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocolWilliam T Creasman, Shamshad Ali, David G Mutch, et al.
American Journal of Obstetrics and Gynecology|August 11, 2018
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 StudyAshley S Felix, David E Cohn, Theodore M Brasky, et al.
Gynecologic Oncology|July 4, 2021
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysisKimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Journal of the National Cancer Institute|April 5, 2017
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and RecurrenceTheodore M Brasky, Ashley S Felix, David E Cohn, et al.
Gynecologic Oncology|September 4, 2025
Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocolKoji Matsuo, Danielle M Enserro, Jason D Wright, et al.
Obstetrics and Gynecology|January 12, 2019
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian CarcinomaPeter G Rose, James J Java, Ritu Salani, et al.
Pageof 7